Crinetics Pharmaceuticals (CRNX) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class II directors for a three-year term expiring at the 2029 annual meeting.

• Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory approval of named executive officer compensation as disclosed in the proxy statement.

• Proxyholders authorized to vote on other business arising at the meeting or any adjournments.

Board of directors and corporate governance

• Nominees for director positions include Caren Deardorf, Weston Nichols, Ph.D., and Stephanie S. Okey, M.S.

• Directors to serve three-year terms if elected.

Audit committee and external auditor matters

• Proposal to ratify PricewaterhouseCoopers LLP as the independent auditor for the upcoming fiscal year.